 | Neoplasia Home |
| Register |
| Submit Manuscript |
| Submit Review |
| Manuscript Status |
| FAQs |
| Contributor Instructions |
| Editorial Board |
| Back Issue Order |
| Contact Us |
| Cancer News |
 June 2008 Volume 10, Number 6 |
Cover Illustration: The cover represents an artistic depiction of an orthotopic model of prostate cancer. The model was used to evaluate the efficacy of novel compounds in the treatment of prostate cancer |
TABLE OF CONTENTS
Research Article |
| Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker |
| Maya Golan, Amnon Hizi, James H Resau, Neora Yaal-Hahoshen, Hadar Reichman, Iafa Keydar and Ilan Tsarfaty |
| Abstract Full Article |
| PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations |
| Katsuhiko Nosho, Takako Kawasaki, Mutsuko Ohnishi, Yuko Suemoto, Gregory J Kirkner, Dimity Zepf, Liying Yan, Janina A Longtine, Charles S Fuchs and Shuji Ogino |
| Abstract Full Article |
| A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer |
| Ali Naderi and Luke Hughes-Davies |
| Abstract Full Article |
| Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells |
| Irina Nazarenko, Rachid Marhaba, Eli Reich, Elena Voronov, Mario Vitacolonna, Dagmar Hildebrand, Elena Elter, Mohini Rajasagi, Ron N Apte and Margot Zöller |
| Abstract Full Article |
| Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas |
| Ping Gu, Xiangbin Xing, Marc Taenzer, Christoph Röcken, Wilko Weichert, Audrius Ivanauskas, Matthias Pross, Ulrich Peitz, Peter Malfertheiner, Roland M Schmid and Matthias Ebert |
| Abstract Full Article |
| UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers |
| Tatjana Mijatovic, Tina Mahieu, Nancy De Nève, Janique Dewelle, Gentiane Simon, Mischael JM Dehoux, Ellen van der Aar, Benjamin Haibe-Kains, Gianluca Bontempi, Christine Deacestecker, Eric Van quaquebeke, Francis Darro and Robert Kiss |
| Abstract Full Article |
| Cyclic pifithrin-á sensitizes wild-type p53 tumor cells to antimicrotubule agent-induced apoptosis |
| Valentina Zuco and Franco Zunino |
| Abstract Full Article |
| Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small-cell lung cancer |
| Rajuc C Reddy, Anjaiah Srirangam, Kaunteya Reddy, Jun Chen, Srinivasareddy Gangireddy, Gregory P Kalemkerian, Theodore J Standiford and Venkateshwar Keshamouni |
| Abstract Full Article |
| Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas |
| Gilson Baia, Stefano Stifani, Edna T Kimura, Michael W McDermott, Russell O Pieper and Anita Lal |
| Abstract Full Article |
| Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-VEGF-A therapy |
| Lisa D Volk, Michael J Flister, Christopher M. Bivens, Alan Stutzman, Neil Desai, Vuong Trieu and Sophia Ran |
| Abstract Full Article |
| Inhibiton of glycogen-synthase kinase-3 (GSK-3) in androgen responsive prostate cancer cell lines. Are GSK-inhibitors therapeutically useful? |
| Ludwig Rinnab, Stefanie V Schütz, Jeannine Diesch, Evi Schmid, Rainer Kuefer, Richard E. Hautmann, Klaus-Dieter Spindler and Marcus V Cronauer |
| Abstract Full Article |
Why should you choose Neoplasia?
© Neoplasia 2010